Orange Book product · Generic (ANDA)
CEFOXITIN
CEFOXITIN SODIUM
At a glance
Jun 12, 2009
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 12, 2009
17 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFOXITIN SODIUM
Strength
EQ 1GM BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 065414
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of CEFOXITIN SODIUM
- 2006CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINERBrand (NDA)
NDA 065214 · B BRAUN
- 1984MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINERBrand (NDA)
NDA 050581 · MERCK
- —MEFOXINBrand (NDA)
NDA 050517 · PHARMOBEDIENT
- 2015CEFOXITIN IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 200938 · SAMSON MEDCL
- 2011CEFOXITINGeneric (ANDA)
ANDA 065467 · ACS DOBFAR SPA
- 2011CEFOXITINGeneric (ANDA)
ANDA 065464 · ACS DOBFAR SPA
- 2010CEFOXITINGeneric (ANDA)
ANDA 065415 · ACS DOBFAR
- 2010CEFOXITINGeneric (ANDA)
ANDA 065238 · HIKMA FARMACEUTICA
- 2010CEFOXITINGeneric (ANDA)
ANDA 065239 · HIKMA FARMACEUTICA
- 2006CEFOXITINGeneric (ANDA)
ANDA 065312 · HOSPIRA INC
- 2006CEFOXITINGeneric (ANDA)
ANDA 065313 · HOSPIRA INC
- 2000CEFOXITINGeneric (ANDA)
ANDA 065051 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
